Anabolic steroids use is commonly perceived to be the domain of the higher echelons of competitive athletes. However, a great deal of anabolic steroid use occurs in private gymnasia (non-local authority) among noncompetitive recreational athletes. Our study has attempted to give an insight into the prevalence of the use of these drugs, the hazards associated with it, and the public health responses which we have adopted. 
Results
One has to appreciate the difficulties involved in making an assessment of the denominator. This is because, with privately owned gymnasia, the people attending are usually not formally registered and pay for attendance either on a weekly, monthly or yearly basis, so the difficulties in making the assessment of total numbers using the facility concerned can be appreciated. This assessment was provided by the gymnasium owner or manager.
Private gymnasia Out of an estimated population sample of 300 people, 160 responses were received, a 53.3% response rate. Of the 160, 62 admitted having taken steroids (38.8%). Reasons for training are given in Table 1 , and 
Discussion
To anyone who attends gymnasia on a regular basis, it is not too difficult to see that the prevalence of anabolic steroid abuse has increased in the past two decades, but especially so in the last 5-10 years. A response rate of 53.3% in such a study is one to be commended in view of the subject studied and its covert nature. The rate of use of 38.8% was consistent with the authors' suspicions and those in the relevant fraternities with whom the authors consulted before the study.
However, one problem which could be foreseen before undertaking the study was an assessment of the size of the denominator. It is to be hoped that our figure is realistic because managers and owners are well aware of the number of people attending their gymnasia as their income is a reflection of this.
The high proportion of steroid users who use both routes of administration indicates possible polypharmacy in these individuals and may reflect on what is available at different times.
With over 58% of those who have injected, injecting 30 times or more, one can assume that we are seeing committed anabolic steroid use. A similar figure of 57.4% of injectors admitted to injecting in the past year, showing that anabolic steroid misuse is a current issue. This is supported by the fact that 50% had taken oral anabolic steroids in the past year and 56.4% had taken tablets on 30 or more occasions.
An initial concern before undertaking the study was the possibility of HIV transmission from possible 'needle sharing' among individuals injecting anabolic steroids. As confirmed by the study, eight people had been involved in some form of needle sharing activity. Atkins5 claims that there could be a rapid spread of HIV among anabolic steroid users as needle sharing is becoming increasingly prevalent. Sklarek6 reported such a case in 1988. Scott et al.7 also report a similar case. There is also some evidence from Atkins5 concerning the sharing of injecting equipment with amphetamine users in the Midlands. Another aspect of the injection problem is that some products are in ready-loaded syringes in a singledose form, thereby creating the possible problem of an inadequate means for disposal of used injecting equipment. Anabolic steroid users in our area are increasingly encouraged to use the NES available, to try to alleviate the above problems by a harm reduction programme. One side-effect of anabolic steroid misuse is an alteration of cholesterol metabolism in the form of decreased high-density lipoprotein levels and raised low-density lipoprotein levels8-10.
This, taken together with another side-effect, i.e. hypertension, may sow the seeds for premature coronary artery disease and atherosclerosis. The long-term effects of prolonged anabolic steroid administration have not been determined in relation to atherosclerotic disease, but in a study of 29 athletes who died suddenly, three of the deaths were due to coronary artery disease1. Unfortunately the review did not address the possibility of anabolic steroid misuse as a contributory factor. Data from animal studies show that these drugs can also lead to changes in mitochondria and myofibrils of cardiac 12 13 tissue . With this in mind, we may be seeing the start of premature coronary artery disease in these people.
It was refreshing to note that the study did not detect any anabolic steroid users under the age of 20 years as there is evidence from several studies that ana -alic steroids can cause premature epiphyseal closure resulting in growth stunting"4 15 . What was not so reassuring was that l'6Y/o ooFusers had used Equipoise (Squibb, Hounslow, UK; original drug no longer manufactured -only counterfeits available), which is a veterinary drug ( Table 4) .
As the results show, over 70% of people taking steroids do so for body building alone, and if grouped together with power lifting, form over 80% of all steroid-taking individuals. The people in the above fraternities need to recognize that even though they look far more healthy, and indeed feel more healthy, than the typical illicit drug abuser, if one shares injecting equipment for any drug, one is indulging in high-risk behaviour for HIV, and attendance at NES is encouraged. There are also other differences between the two groups of abusers, namely that the intravenous drug abuser appears to be better informed of the practical aspects of his habit (e.g. injecting technique), whereas anabolic steroid users do not appear to possess such an extensive knowledge (as experienced by those working at the NES). Anabolic steroid users usually request longer and bigger bore needles when attending NES, as some steroids are viscous and oil-based and a longer needle is preferred for intramuscular injection. Although needle sharing in the geographical area studied does not seem to be as prevalent as it could obviously be, we are currently participating in a poster campaign with a local NES, which has boosted attendance figures eightfold.
The reader may be puzzled to see diuretics, tamoxifen and thyroxine listed. Diuretics are used to achieve greater muscle definition by antagonizing the water retention which is sometimes seen as a side-effect of anabolic steroid use. Tamoxifen is used to prevent or control gynaecomastia, which can occur with anabolic steroid use. Thyroxine is taken to increase the body's metabolic rate.
At present, those people taking steroids rely on word-of-mouth advice of experienced steroid users and various handbooks.
The current notion of 'harm minimization', so prevalent in the illicit drugs field, should be broadened to include anabolic steroids, whereby NES should be made more accessible and users be made more aware of their existence. In the light of these findings, the medical profession should be made aware of the existence of anabolic steroid use and how to deal with it when confronted.
